|
Re: Next Hurdle
|
2
|
Resverlogix Corp.
|
Jan 06, 2018 12:20PM
|
|
Re: Que sera sera....
|
2
|
Resverlogix Corp.
|
Apr 06, 2018 02:51PM
|
|
Re: NEW BLOG POST
|
2
|
Resverlogix Corp.
|
Jun 18, 2015 08:27AM
|
|
Re: Another country listed on EU Clinical Trial Register for BETonMACE
|
2
|
Resverlogix Corp.
|
Dec 10, 2015 08:35AM
|
|
Re: We Need The Futility Analysis
|
2
|
Resverlogix Corp.
|
Feb 08, 2018 01:21PM
|
|
Re: 96 hours
|
2
|
Resverlogix Corp.
|
Aug 23, 2017 05:00PM
|
|
Re: RVX continuous good news
|
2
|
Resverlogix Corp.
|
Jun 04, 2015 11:27AM
|
|
Re: The Longer It Lasts, The Better It Is???
|
2
|
Resverlogix Corp.
|
Dec 22, 2015 08:28AM
|
|
Re: Apabetalone MOA diagram
|
2
|
Resverlogix Corp.
|
Sep 28, 2019 02:57PM
|
|
Re: Lobbying Firm and Resverlogix
|
2
|
Resverlogix Corp.
|
Jul 15, 2017 12:31PM
|
|
Re: Hide the Ball
|
2
|
Resverlogix Corp.
|
Jun 09, 2016 12:00PM
|
|
Zenith Shareholders
|
2
|
Zenith Epigenetics
|
Aug 31, 2021 08:04PM
|
|
Re: I second that train of thought !!!
|
2
|
Resverlogix Corp.
|
Dec 02, 2015 10:31AM
|
|
Glucose fluctuation
|
2
|
Resverlogix Corp.
|
Jun 14, 2015 11:37AM
|
|
Re: Update
|
2
|
Zenith Epigenetics
|
Jul 15, 2017 12:40PM
|
|
Re: Slides from Resverlogix Corporate Update 6/13/16
|
2
|
Resverlogix Corp.
|
Jun 13, 2016 05:16PM
|
|
Re: Additional Exempt Distributions
|
2
|
Zenith Epigenetics
|
Oct 13, 2023 03:59PM
|
|
Re: No data, No communication,,no interest!!
|
2
|
Zenith Epigenetics
|
Jan 05, 2024 09:15AM
|
|
Re: Chinese Takeovers
|
2
|
Zenith Epigenetics
|
Mar 08, 2018 11:53AM
|
|
Re: Genentech/Roche BET inhibitor toxicity paper
|
2
|
Resverlogix Corp.
|
Apr 20, 2016 09:36AM
|
